N
Natco Pharma
NATCOPHARM Share Price
Healthcare1,004.50
as on 09 Mar 2026 at 10:53
Market Cap
₹17,992 Cr
PE Ratio
11.70
ROCE
30.12%
NATCOPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
17,992
PE Ratio
11.70
PB Ratio
2.11
Dividend Yield
0.59%
ROE
24.74%
ROCE
30.12%
Book Value (₹)
482.93
Face Value (₹)
2.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 49.62% | 49.56% | 49.56% | 49.48% | 49.48% |
| Domestic Institutional Investors (DII) | 5.57% | 5.65% | 5.82% | 5.87% | 5.39% |
| Foreign Institutional Investors (FII) | 17.94% | 17.49% | 15.51% | 14.09% | 15.16% |
| Public Investors | 23.34% | 23.68% | 25.22% | 25.84% | 25.38% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NATCOPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
524816
NSE Scrip Name
NATCOPHARM
ISIN
INE987B01026



